m-C-tri(CH2-PEG1-NHS ester), 250mg

5-Bromo-1-methylpyrimidine-2,4(1h,3h)-dione, 97%, 100mg

1-Bromo-2,4-dimethyl-3-nitrobenzene, 97+%, 250mg

2-methyl-1-(2-methylbenzoyl)piperazine, 95.0%, 2g

4-ethyl-1,3-thiazol-2-amine, 95.0%, 100g

1-(3-Chloro-4-methylphenyl)guanidine, 95.0%, 250mg

5-[3-(methylsulfonyl)phenyl]-1,3,4-oxadiazol-2-amine, 95.0%, 250mg

2,2-dimethyl-1-(3-methyl-2-thienyl)cyclopropanecarboxylic acid, 95.0%, 250mg

2-Chloro-3-fluoro-4-formylpyridine, 97.0%, 100g

(R)-3-(4-Chloro-phenylsulfanyl)-pyrrolidine-1-carboxylic acid tert-butyl ester, 95.0%, 100mg

4-([2,2':6',2''-Terpyridin]-4'-yl)benzaldehyde, 97%, 5g

4-(chloromethyl)-5-methyl-1,3-oxazole, 95.0%, 1g

Methyl 2-hydroxy-3-isopropylbenzoate, 98%, 5g